Literature DB >> 27446349

Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus.

Chunye Chen1, Yuan Zeng1, Jing Xu2, Hongting Zheng2, Jun Liu3, Rong Fan3, Wenyi Zhu3, Lijia Yuan1, Yu Qin1, Shihui Chen1, Yong Zhou1, Ying Wu1, Jing Wan1, Mantian Mi1, Jian Wang3.   

Abstract

Soluble dietary fiber (DF) reduces the risk of developing diabetes and may have therapeutic effects in patients with type 2 diabetes mellitus (DM2). The present study aimed to investigate the effect of soluble DF on metabolic control in patients with DM2. A total of 117 patients with DM2 between the ages of 40 and 70 were assessed. Patients were randomly assigned to one of two groups, and administered extra soluble DF (10 or 20 g/day), or to a control group (0 g/day) for one month. Blood glucose, serum insulin and connecting peptide (C-peptide) levels, and the insulin resistance index, as determined using the homeostatic model assessment method, were measured during fasting and up to 2-h postprandially prior to and following one month of treatment. Other measurements included serum levels of glycated albumin (GA), blood lipid profiles, and an analysis of the blood pressure, body weight and waist/hip ratio of all patients. Following intervention, the levels of 2-h blood glucose, fasting insulin and lipoprotein(a), and the insulin resistance index, were significantly improved in all groups. Furthermore, the fasting blood glucose, 2-h insulin, fasting C-peptide, 2-h C-peptide, GA and triglyceride (TG) levels were significantly improved in the soluble DF groups. The 20 g/day soluble DF group exhibited significantly improved fasting blood glucose and low-density lipoprotein levels, as well as a significantly improved insulin resistance index. In addition, 10 and 20 g/day soluble DF significantly improved the waist and hip circumferences and levels of TGs and apolipoprotein A. The results of the present study suggested that increased and regular consumption of soluble DF led to significant improvements in blood glucose levels, insulin resistance and metabolic profiles, without improving the secretory function of the islets of Langerhans, over a short-term intervention period in patients with DM2.

Entities:  

Keywords:  blood glucose; glycated albumin; insulin resistance index; soluble dietary fiber; type 2 diabetes mellitus

Year:  2016        PMID: 27446349      PMCID: PMC4950069          DOI: 10.3892/etm.2016.3377

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  46 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.

Authors:  Satomi Takahashi; Hiroshi Uchino; Tomoaki Shimizu; Akio Kanazawa; Yoshifumi Tamura; Ken Sakai; Hirotaka Watada; Takahisa Hirose; Ryuzo Kawamori; Yasushi Tanaka
Journal:  Endocr J       Date:  2006-12-11       Impact factor: 2.349

3.  Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.

Authors:  Masaaki Inaba; Senji Okuno; Yasuro Kumeda; Shinsuke Yamada; Yasuo Imanishi; Tsutomu Tabata; Mikio Okamura; Shigeki Okada; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

Review 4.  [Dietary fiber--adequate intake and effects on metabolism health].

Authors:  Fernanda Sarmento Rolla Bernaud; Ticiana C Rodrigues
Journal:  Arq Bras Endocrinol Metabol       Date:  2013-08

Review 5.  C-peptide: an index of insulin secretion.

Authors:  O K Faber; C Binder
Journal:  Diabetes Metab Rev       Date:  1986

6.  Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain.

Authors:  Patricia Enes; María Martín-Frías; Ma Ángeles Álvarez; Rosa Yelmo; Milagros Alonso; Raquel Barrio
Journal:  Diabetes Res Clin Pract       Date:  2014-09-17       Impact factor: 5.602

7.  Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.

Authors:  K S Park; T P Ciaraldi; K Lindgren; L Abrams-Carter; S Mudaliar; S E Nikoulina; S R Tufari; J H Veerkamp; A Vidal-Puig; R R Henry
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

Review 8.  Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions.

Authors:  Athanasios Papathanasopoulos; Michael Camilleri
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

9.  Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.

Authors:  Kazutomi Yoshiuchi; Munehide Matsuhisa; Naoto Katakami; Yoshihisa Nakatani; Kenya Sakamoto; Takaaki Matsuoka; Yutaka Umayahara; Keisuke Kosugi; Hideaki Kaneto; Yoshimitsu Yamasaki; Masatsugu Hori
Journal:  Endocr J       Date:  2008-04-30       Impact factor: 2.349

Review 10.  Water-soluble dietary fibers and cardiovascular disease.

Authors:  Elke Theuwissen; Ronald P Mensink
Journal:  Physiol Behav       Date:  2008-01-05
View more
  5 in total

1.  Semi-modified okara whey diet increased insulin secretion in diabetic rats fed a basal or high fat diet.

Authors:  Ahmed E Abdel-Mobdy; Marwa S Khattab; Ebtesam A Mahmoud; Eman R Mohamed; Emam A Abdel-Rahim
Journal:  Food Sci Biotechnol       Date:  2020-11-04       Impact factor: 2.391

2.  Effects of Serum C-Peptide Level on Blood Lipid and Cardiovascular and Cerebrovascular Injury in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.

Authors:  Juan Qin; Rongli Sun; Ding Ding
Journal:  Contrast Media Mol Imaging       Date:  2022-04-08       Impact factor: 3.009

Review 3.  The effects of dietary fiber on common complications in critically ill patients; with a special focus on viral infections; a systematic reveiw.

Authors:  Azadeh Hajipour; Maryam Afsharfar; Mona Jonoush; Mina Ahmadzadeh; Maryam Gholamalizadeh; Naeemeh Hassanpour Ardekanizadeh; Saeid Doaei; Fatemeh Mohammadi-Nasrabadi
Journal:  Immun Inflamm Dis       Date:  2022-05

4.  Ethnopharmacological values of cassava and its potential for diabetes and dyslipidemia management: Knowledge survey and critical review of report.

Authors:  Ezekiel Uba Nwose; Bonaventure C Onodu; Anayochukwu Edward Anyasodor; Mathew O Sedowo; John N Okuzor; Richard J Culas
Journal:  J Intercult Ethnopharmacol       Date:  2017-06-09

5.  The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study.

Authors:  Harsha Suresh; Jerry Zhou; Vincent Ho
Journal:  Nutrients       Date:  2021-11-28       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.